Atlas Trials

Mesenchymal Stem Cells in NPM1 Mutated Low Risk Acute Myeloid Leukemia: a Study of the Tumor Microenvironment and Its Contribution to the Outcome

Clinical trial NCT07379528 · COMPLETED

Trial details

NCT number
NCT07379528
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Status
COMPLETED
Study type
OBSERVATIONAL
Acute Myeloid Leukaemia (AML)
Start date
2023-03-15
Primary completion
2025-02-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.